Industry Experts

Kaiyuan Jiang is an Associate Director of cell therapy process development at Johnson & Johnson Innovative Medicine. He is currently leading a team to develop next-generation cell manufacturing platforms for CAR-T cell therapy programs. Kaiyuan was a senior engineer and team lead to support the research, process development, technology transfer and regulatory submission of several clinical CAR-T programs at Kite/Gilead Sciences. He graduated from the PhD program of Biomedical Engineering at University of Florida. His experience was focused on developing immunomodulating strategies for cell transplantation treating Type 1 diabetes, as well as end-to-end drug product development of autologous and allogeneic CAR-T cell therapies.